启明创投

启明创投

@author-1788515151757110

启明创投致力于成为中国优秀技术创业者们的首选投资机构

345 articles

Articles

Qiming Venture Partners and Over 10 Portfolio Companies Named to 2024 China Healthcare Industry Investment Glory List

Qiming Venture Partners and Over 10 Portfolio Companies Named to 2024 China Healthcare Industry Investment Glory List

The list not only recognizes outstanding investment institutions, investors, and companies, but also provides directional guidance for the evolution of industry investment logic, redefines the value standards for talent, and brings positive momentum to the industrial ecosystem.

Qiming Star | CANbridge Pharma's velaglucerase alfa for injection (brand name: Gerining), a first-in-class drug for Type I and Type III Gaucher disease, approved for market launch in China

Qiming Star | CANbridge Pharma's velaglucerase alfa for injection (brand name: Gerining), a first-in-class drug for Type I and Type III Gaucher disease, approved for market launch in China

Gorenicin is not only the third rare disease treatment drug launched by CANbridge after Hymricin and Myrbetriq, but also the first self-developed product poised for commercialization.

Qiming View | Duane Kuang: The Time Is Ripe for Chinese Tech to Go Global

Qiming View | Duane Kuang: The Time Is Ripe for Chinese Tech to Go Global

China's technology going global — the time is now. In the coming years, all kinds of our AI-related technologies will join this wave of going global as well. The trend of Chinese technology expanding worldwide is only just beginning.

Qiming Venture Partners portfolio companies StepFun and Yuanli Lingji forge strategic partnership

Qiming Venture Partners portfolio companies StepFun and Yuanli Lingji forge strategic partnership

The two parties will engage in deep collaboration on embodied large-model algorithm R&D, multimodal data closed loops, and robotics scenario applications, jointly tackling the key technical challenges of bringing RoboAgent into the physical world. Going forward, they plan to co-establish a joint lab to accelerate technology iteration and commercial validation, and to explore long-term collaboration in open-source ecosystems, vertical industries, and other domains.